+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biosensors for Point-of-Care Diagnostics Market - Global Biosensors for Point-of-Care Diagnostics Industry Analysis, Size, Share, Growth, Trends, Regional Outlook & Forecast 2023-2030 (By Product, By Transducer, By Application, By End User, By Geographic Coverage and By Company)

  • PDF Icon

    Report

  • 210 Pages
  • August 2023
  • Region: Global
  • Fairfield Market Research
  • ID: 5864917
As the report suggests, the market for biosensors for POC diagnostics is projected to reach a valuation of US$22.12 Bn by the end of 2030, with remarkable growth opportunities anticipated in major regional markets of Asia Pacific, and North America. The biosensors for point-of-care diagnostics market is expected to witness substantial expansion between 2023 and 2030, at an estimated CAGR of 8.5%.

The comprehensive study provides a detailed growth analysis and forecast for the biosensors for point-of-care diagnostics market over the projected years. Commenting on the findings, the analyst states, 'The highly sophisticated healthcare infrastructure will continue to enhance the attractiveness of the North American market. Meanwhile, Asia Pacific is poised to maintain its dominant market positioning throughout the assessment period. Additionally, a plethora of untapped opportunities exists in underserved regions.'

Molecular Diagnostic Biosensors Segment - Leading the Way

The report underscores the dominance of the molecular diagnostic biosensors segment in the global market during the forecast period. These biosensors play a crucial role in identifying and measuring nucleic acids, proteins, or other substances at the molecular level, enabling rapid and precise results.

Molecular diagnostic biosensors have played a pivotal role in the early detection of infectious diseases caused by viruses, bacteria, and other pathogens. Conditions such as COVID-19, influenza, HIV, hepatitis, and tuberculosis have immensely benefited from these biosensors, allowing for swift diagnosis and timely intervention.

Moreover, these biosensors have significantly contributed to cancer diagnostics by identifying specific biomarkers associated with various cancer types. This capability facilitates early detection, assessment of treatment efficacy, and monitoring disease progression based on genetic alterations or specific disease-related proteins.

Glucose Testing Segment Expects Exponential Growth in Sales

Anticipated as the fastest-growing category, the glucose testing segment is poised for remarkable expansion within the biosensors for point-of-care diagnostics market. The prevalence of diabetes as a chronic condition characterised by elevated blood sugar levels has spurred the revolutionary use of biosensors for glucose testing.

Glucose biosensors find extensive application in blood glucose meters, and continuous glucose monitoring (CGM) systems, enabling diabetic individuals to conveniently monitor their blood sugar levels on a regular basis. This data plays a pivotal role in informed decision-making regarding dietary choices, medication management, and physical activity.

Furthermore, ongoing research into non-invasive glucose biosensors aims to provide blood sugar level testing without the need for traditional fingersticks. Transdermal sensing, optical sensors, and saliva-based testing represent some of the innovative methods under exploration, offering glucose readings without blood extraction.

This advancement paves the way for personalised diabetes management, empowering patients, and healthcare professionals to adjust lifestyle choices and medication dosages based on real-time information.

Dominance of Asia Pacific Prevails

The report emphasizes the dominant role of the Asia Pacific region in driving the biosensors for point-of-care diagnostics market during the forecast period. Numerous countries in the region have actively endorsed the adoption of cutting-edge medical technologies, including biosensors, with governmental support, funding initiatives, and favourable regulatory frameworks.

Wearable biosensors, such as smartwatches and fitness bands, have gained immense popularity in the Asia Pacific region. These devices continuously monitor vital signs and health parameters, providing valuable health insights to consumers.

Demand Surges in North America

The North American market for biosensors for point-of-care diagnostics is expected to exhibit the fastest growth rate. The region's extensive embrace of telemedicine and virtual care presents opportunities for integrating biosensors into telemedicine platforms. This integration facilitates transparent data exchange between healthcare providers and biosensors, enhancing virtual consultations and expediting decision-making.

The rising demand for rapid and accurate point-of-care testing is particularly evident in non-traditional healthcare settings, including pharmacies, schools, workplaces, and community clinics. These settings offer valuable solutions for immediate diagnoses.

Key Market Players

Danaher Corporation, Zimmer & Peacock AS, Bio-Rad Laboratories Inc., Medtronic plc, Abbott Laboratories, Koninklijke Philips N.V., Biosensors International Group, Ltd., Johnson & Johnson, DuPont, LifeScan, Inc., Nova Biomedical, Roche, QTL Biodetection LLC, Siemens Healthineers AG

Table of Contents

1. Executive Summary
1.1. Global Biosensors for Point-of-Care Diagnostics Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2022
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. Covid-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Biosensors for Point-of-Care Diagnostics Market Outlook, 2018 - 2030
3.1. Global Biosensors for Point-of-Care Diagnostics Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
3.1.1. Key Highlights
3.1.1.1. Biomarkers
3.1.1.2. Bioreceptors
3.1.1.3. Molecular Diagnostic Biosensors
3.2. Global Biosensors for Point-of-Care Diagnostics Market Outlook, by Transducer, Value (US$ Bn), 2018 - 2030
3.2.1. Key Highlights
3.2.1.1. Thermal
3.2.1.2. Piezoelectric
3.2.1.3. Electrochemical
3.2.1.4. Optical
3.2.1.5. Other
3.3. Global Biosensors for Point-of-Care Diagnostics Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
3.3.1. Key Highlights
3.3.1.1. Fertility and Pregnancy
3.3.1.2. Glucose Testing
3.3.1.3. Hb1Ac Testing
3.3.1.4. Infectious Disease
3.3.1.5. Cardiac Markers
3.3.1.6. Cancer Markers
3.3.1.7. Drug-of-Abuse Testing
3.3.1.8. Coagulation Testing
3.3.1.9. Hormone Analysis
3.3.1.10. Others
3.4. Global Biosensors for Point-of-Care Diagnostics Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
3.4.1. Key Highlights
3.4.1.1. Clinics
3.4.1.2. Hospitals
3.4.1.3. Home Care Service Providers
3.4.1.4. Assisted Living Healthcare Centers
3.4.1.5. Research Laboratory
3.5. Global Biosensors for Point-of-Care Diagnostics Market Outlook, by Region, Value (US$ Bn), 2018 - 2030
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Biosensors for Point-of-Care Diagnostics Market Outlook, 2018 - 2030
4.1. North America Biosensors for Point-of-Care Diagnostics Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
4.1.1. Key Highlights
4.1.1.1. Biomarkers
4.1.1.2. Bioreceptors
4.1.1.3. Molecular Diagnostic Biosensors
4.2. North America Biosensors for Point-of-Care Diagnostics Market Outlook, by Transducer, Value (US$ Bn), 2018 - 2030
4.2.1. Key Highlights
4.2.1.1. Thermal
4.2.1.2. Piezoelectric
4.2.1.3. Electrochemical
4.2.1.4. Optical
4.2.1.5. Other
4.3. North America Biosensors for Point-of-Care Diagnostics Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
4.3.1. Key Highlights
4.3.1.1. Fertility and Pregnancy
4.3.1.2. Glucose Testing
4.3.1.3. Hb1Ac Testing
4.3.1.4. Infectious Disease
4.3.1.5. Cardiac Markers
4.3.1.6. Cancer Markers
4.3.1.7. Drug-of-Abuse Testing
4.3.1.8. Coagulation Testing
4.3.1.9. Hormone Analysis
4.3.1.10. Others
4.4. North America Biosensors for Point-of-Care Diagnostics Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
4.4.1. Key Highlights
4.4.1.1. Clinics
4.4.1.2. Hospitals
4.4.1.3. Home Care Service Providers
4.4.1.4. Assisted Living Healthcare Centers
4.4.1.5. Research Laboratory
4.4.2. Market Attractiveness Analysis
4.5. North America Biosensors for Point-of-Care Diagnostics Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
4.5.1. Key Highlights
4.5.1.1. U.S. Biosensors for Point-of-Care Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
4.5.1.2. U.S. Biosensors for Point-of-Care Diagnostics Market Transducer, Value (US$ Bn), 2018 - 2030
4.5.1.3. U.S. Biosensors for Point-of-Care Diagnostics Market Application, Value (US$ Bn), 2018 - 2030
4.5.1.4. U.S. Biosensors for Point-of-Care Diagnostics Market End User, Value (US$ Bn), 2018 - 2030
4.5.1.5. Canada Biosensors for Point-of-Care Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
4.5.1.6. Canada Biosensors for Point-of-Care Diagnostics Market Transducer, Value (US$ Bn), 2018 - 2030
4.5.1.7. Canada Biosensors for Point-of-Care Diagnostics Market Application, Value (US$ Bn), 2018 - 2030
4.5.1.8. Canada Biosensors for Point-of-Care Diagnostics Market End User, Value (US$ Bn), 2018 - 2030
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Biosensors for Point-of-Care Diagnostics Market Outlook, 2018 - 2030
5.1. Europe Biosensors for Point-of-Care Diagnostics Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
5.1.1. Key Highlights
5.1.1.1. Biomarkers
5.1.1.2. Bioreceptors
5.1.1.3. Molecular Diagnostic Biosensors
5.2. Europe Biosensors for Point-of-Care Diagnostics Market Outlook, by Transducer, Value (US$ Bn), 2018 - 2030
5.2.1. Key Highlights
5.2.1.1. Thermal
5.2.1.2. Piezoelectric
5.2.1.3. Electrochemical
5.2.1.4. Optical
5.2.1.5. Other
5.3. Europe Biosensors for Point-of-Care Diagnostics Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
5.3.1. Key Highlights
5.3.1.1. Fertility and Pregnancy
5.3.1.2. Glucose Testing
5.3.1.3. Hb1Ac Testing
5.3.1.4. Infectious Disease
5.3.1.5. Cardiac Markers
5.3.1.6. Cancer Markers
5.3.1.7. Drug-of-Abuse Testing
5.3.1.8. Coagulation Testing
5.3.1.9. Hormone Analysis
5.3.1.10. Others
5.4. Europe Biosensors for Point-of-Care Diagnostics Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
5.4.1. Key Highlights
5.4.1.1. Clinics
5.4.1.2. Hospitals
5.4.1.3. Home Care Service Providers
5.4.1.4. Assisted Living Healthcare Centers
5.4.1.5. Research Laboratory
5.4.2. BPS Analysis/Market Attractiveness Analysis
5.5. Europe Biosensors for Point-of-Care Diagnostics Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
5.5.1. Key Highlights
5.5.1.1. Germany Biosensors for Point-of-Care Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
5.5.1.2. Germany Biosensors for Point-of-Care Diagnostics Market Transducer, Value (US$ Bn), 2018 - 2030
5.5.1.3. Germany Biosensors for Point-of-Care Diagnostics Market Application, Value (US$ Bn), 2018 - 2030
5.5.1.4. Germany Biosensors for Point-of-Care Diagnostics Market End User, Value (US$ Bn), 2018 - 2030
5.5.1.5. U.K. Biosensors for Point-of-Care Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
5.5.1.6. U.K. Biosensors for Point-of-Care Diagnostics Market Transducer, Value (US$ Bn), 2018 - 2030
5.5.1.7. U.K. Biosensors for Point-of-Care Diagnostics Market Application, Value (US$ Bn), 2018 - 2030
5.5.1.8. U.K. Biosensors for Point-of-Care Diagnostics Market End User, Value (US$ Bn), 2018 - 2030
5.5.1.9. France Biosensors for Point-of-Care Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
5.5.1.10. France Biosensors for Point-of-Care Diagnostics Market Transducer, Value (US$ Bn), 2018 - 2030
5.5.1.11. France Biosensors for Point-of-Care Diagnostics Market Application, Value (US$ Bn), 2018 - 2030
5.5.1.12. France Biosensors for Point-of-Care Diagnostics Market End User, Value (US$ Bn), 2018 - 2030
5.5.1.13. Italy Biosensors for Point-of-Care Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
5.5.1.14. Italy Biosensors for Point-of-Care Diagnostics Market Transducer, Value (US$ Bn), 2018 - 2030
5.5.1.15. Italy Biosensors for Point-of-Care Diagnostics Market Application, Value (US$ Bn), 2018 - 2030
5.5.1.16. Italy Biosensors for Point-of-Care Diagnostics Market End User, Value (US$ Bn), 2018 - 2030
5.5.1.17. Russia Biosensors for Point-of-Care Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
5.5.1.18. Russia Biosensors for Point-of-Care Diagnostics Market Transducer, Value (US$ Bn), 2018 - 2030
5.5.1.19. Russia Biosensors for Point-of-Care Diagnostics Market Application, Value (US$ Bn), 2018 - 2030
5.5.1.20. Russia Biosensors for Point-of-Care Diagnostics Market End User, Value (US$ Bn), 2018 - 2030
5.5.1.21. Rest of Europe Biosensors for Point-of-Care Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
5.5.1.22. Rest of Europe Biosensors for Point-of-Care Diagnostics Market Transducer, Value (US$ Bn), 2018 - 2030
5.5.1.23. Rest of Europe Biosensors for Point-of-Care Diagnostics Market Application, Value (US$ Bn), 2018 - 2030
5.5.1.24. Rest of Europe Biosensors for Point-of-Care Diagnostics Market End User, Value (US$ Bn), 2018 - 2030
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Biosensors for Point-of-Care Diagnostics Market Outlook, 2018 - 2030
6.1. Asia Pacific Biosensors for Point-of-Care Diagnostics Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
6.1.1. Key Highlights
6.1.1.1. Biomarkers
6.1.1.2. Bioreceptors
6.1.1.3. Molecular Diagnostic Biosensors
6.2. Asia Pacific Biosensors for Point-of-Care Diagnostics Market Outlook, by Transducer, Value (US$ Bn), 2018 - 2030
6.2.1. Key Highlights
6.2.1.1. Thermal
6.2.1.2. Piezoelectric
6.2.1.3. Electrochemical
6.2.1.4. Optical
6.2.1.5. Other
6.3. Asia Pacific Biosensors for Point-of-Care Diagnostics Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
6.3.1. Key Highlights
6.3.1.1. Fertility and Pregnancy
6.3.1.2. Glucose Testing
6.3.1.3. Hb1Ac Testing
6.3.1.4. Infectious Disease
6.3.1.5. Cardiac Markers
6.3.1.6. Cancer Markers
6.3.1.7. Drug-of-Abuse Testing
6.3.1.8. Coagulation Testing
6.3.1.9. Hormone Analysis
6.3.1.10. Others
6.4. Asia Pacific Biosensors for Point-of-Care Diagnostics Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
6.4.1. Key Highlights
6.4.1.1. Clinics
6.4.1.2. Hospitals
6.4.1.3. Home Care Service Providers
6.4.1.4. Assisted Living Healthcare Centers
6.4.1.5. Research Laboratory
6.4.2. BPS Analysis/Market Attractiveness Analysis
6.5. Asia Pacific Biosensors for Point-of-Care Diagnostics Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
6.5.1. Key Highlights
6.5.1.1. China Biosensors for Point-of-Care Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
6.5.1.2. China Biosensors for Point-of-Care Diagnostics Market Transducer, Value (US$ Bn), 2018 - 2030
6.5.1.3. China Biosensors for Point-of-Care Diagnostics Market Application, Value (US$ Bn), 2018 - 2030
6.5.1.4. China Biosensors for Point-of-Care Diagnostics Market End User, Value (US$ Bn), 2018 - 2030
6.5.1.5. Japan Biosensors for Point-of-Care Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
6.5.1.6. Japan Biosensors for Point-of-Care Diagnostics Market Transducer, Value (US$ Bn), 2018 - 2030
6.5.1.7. Japan Biosensors for Point-of-Care Diagnostics Market Application, Value (US$ Bn), 2018 - 2030
6.5.1.8. Japan Biosensors for Point-of-Care Diagnostics Market End User, Value (US$ Bn), 2018 - 2030
6.5.1.9. South Korea Biosensors for Point-of-Care Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
6.5.1.10. South Korea Biosensors for Point-of-Care Diagnostics Market Transducer, Value (US$ Bn), 2018 - 2030
6.5.1.11. South Korea Biosensors for Point-of-Care Diagnostics Market Application, Value (US$ Bn), 2018 - 2030
6.5.1.12. South Korea Biosensors for Point-of-Care Diagnostics Market End User, Value (US$ Bn), 2018 - 2030
6.5.1.13. India Biosensors for Point-of-Care Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
6.5.1.14. India Biosensors for Point-of-Care Diagnostics Market Transducer, Value (US$ Bn), 2018 - 2030
6.5.1.15. India Biosensors for Point-of-Care Diagnostics Market Application, Value (US$ Bn), 2018 - 2030
6.5.1.16. India Biosensors for Point-of-Care Diagnostics Market End User, Value (US$ Bn), 2018 - 2030
6.5.1.17. Southeast Asia Biosensors for Point-of-Care Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
6.5.1.18. Southeast Asia Biosensors for Point-of-Care Diagnostics Market Transducer, Value (US$ Bn), 2018 - 2030
6.5.1.19. Southeast Asia Biosensors for Point-of-Care Diagnostics Market Application, Value (US$ Bn), 2018 - 2030
6.5.1.20. Southeast Asia Biosensors for Point-of-Care Diagnostics Market End User, Value (US$ Bn), 2018 - 2030
6.5.1.21. Rest of Asia Pacific Biosensors for Point-of-Care Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
6.5.1.22. Rest of Asia Pacific Biosensors for Point-of-Care Diagnostics Market Transducer, Value (US$ Bn), 2018 - 2030
6.5.1.23. Rest of Asia Pacific Biosensors for Point-of-Care Diagnostics Market Application, Value (US$ Bn), 2018 - 2030
6.5.1.24. Rest of Asia Pacific Biosensors for Point-of-Care Diagnostics Market End User, Value (US$ Bn), 2018 - 2030
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Biosensors for Point-of-Care Diagnostics Market Outlook, 2018 - 2030
7.1. Latin America Biosensors for Point-of-Care Diagnostics Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
7.1.1. Key Highlights
7.1.1.1. Biomarkers
7.1.1.2. Bioreceptors
7.1.1.3. Molecular Diagnostic Biosensors
7.2. Latin America Biosensors for Point-of-Care Diagnostics Market Outlook, by Transducer, Value (US$ Bn), 2018 - 2030
7.2.1. Key Highlights
7.2.1.1. Thermal
7.2.1.2. Piezoelectric
7.2.1.3. Electrochemical
7.2.1.4. Optical
7.2.1.5. Other
7.3. Latin America Biosensors for Point-of-Care Diagnostics Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
7.3.1. Key Highlights
7.3.1.1. Fertility and Pregnancy
7.3.1.2. Glucose Testing
7.3.1.3. Hb1Ac Testing
7.3.1.4. Infectious Disease
7.3.1.5. Cardiac Markers
7.3.1.6. Cancer Markers
7.3.1.7. Drug-of-Abuse Testing
7.3.1.8. Coagulation Testing
7.3.1.9. Hormone Analysis
7.3.1.10. Others
7.4. Latin America Biosensors for Point-of-Care Diagnostics Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
7.4.1. Key Highlights
7.4.1.1. Clinics
7.4.1.2. Hospitals
7.4.1.3. Home Care Service Providers
7.4.1.4. Assisted Living Healthcare Centers
7.4.1.5. Research Laboratory
7.4.2. BPS Analysis/Market Attractiveness Analysis
7.5. Latin America Biosensors for Point-of-Care Diagnostics Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
7.5.1. Key Highlights
7.5.1.1. Brazil Biosensors for Point-of-Care Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
7.5.1.2. Brazil Biosensors for Point-of-Care Diagnostics Market Transducer, Value (US$ Bn), 2018 - 2030
7.5.1.3. Brazil Biosensors for Point-of-Care Diagnostics Market Application, Value (US$ Bn), 2018 - 2030
7.5.1.4. Brazil Biosensors for Point-of-Care Diagnostics Market End User, Value (US$ Bn), 2018 - 2030
7.5.1.5. Mexico Biosensors for Point-of-Care Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
7.5.1.6. Mexico Biosensors for Point-of-Care Diagnostics Market Transducer, Value (US$ Bn), 2018 - 2030
7.5.1.7. Mexico Biosensors for Point-of-Care Diagnostics Market Application, Value (US$ Bn), 2018 - 2030
7.5.1.8. Mexico Biosensors for Point-of-Care Diagnostics Market End User, Value (US$ Bn), 2018 - 2030
7.5.1.9. Rest of Latin America Biosensors for Point-of-Care Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
7.5.1.10. Rest of Latin America Biosensors for Point-of-Care Diagnostics Market Transducer, Value (US$ Bn), 2018 - 2030
7.5.1.11. Rest of Latin America Biosensors for Point-of-Care Diagnostics Market Application, Value (US$ Bn), 2018 - 2030
7.5.1.12. Rest of Latin America Biosensors for Point-of-Care Diagnostics Market End User, Value (US$ Bn), 2018 - 2030
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Biosensors for Point-of-Care Diagnostics Market Outlook, 2018 - 2030
8.1. Middle East & Africa Biosensors for Point-of-Care Diagnostics Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
8.1.1. Key Highlights
8.1.1.1. Biomarkers
8.1.1.2. Bioreceptors
8.1.1.3. Molecular Diagnostic Biosensors
8.2. Middle East & Africa Biosensors for Point-of-Care Diagnostics Market Outlook, by Transducer, Value (US$ Bn), 2018 - 2030
8.2.1. Key Highlights
8.2.1.1. Thermal
8.2.1.2. Piezoelectric
8.2.1.3. Electrochemical
8.2.1.4. Optical
8.2.1.5. Other
8.3. Middle East & Africa Biosensors for Point-of-Care Diagnostics Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
8.3.1. Key Highlights
8.3.1.1. Fertility and Pregnancy
8.3.1.2. Glucose Testing
8.3.1.3. Hb1Ac Testing
8.3.1.4. Infectious Disease
8.3.1.5. Cardiac Markers
8.3.1.6. Cancer Markers
8.3.1.7. Drug-of-Abuse Testing
8.3.1.8. Coagulation Testing
8.3.1.9. Hormone Analysis
8.3.1.10. Others
8.4. Middle East & Africa Biosensors for Point-of-Care Diagnostics Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
8.4.1. Key Highlights
8.4.1.1. Clinics
8.4.1.2. Hospitals
8.4.1.3. Home Care Service Providers
8.4.1.4. Assisted Living Healthcare Centers
8.4.1.5. Research Laboratory
8.4.2. BPS Analysis/Market Attractiveness Analysis
8.5. Middle East & Africa Biosensors for Point-of-Care Diagnostics Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
8.5.1. Key Highlights
8.5.1.1. GCC Biosensors for Point-of-Care Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
8.5.1.2. GCC Biosensors for Point-of-Care Diagnostics Market Transducer, Value (US$ Bn), 2018 - 2030
8.5.1.3. GCC Biosensors for Point-of-Care Diagnostics Market Application, Value (US$ Bn), 2018 - 2030
8.5.1.4. GCC Biosensors for Point-of-Care Diagnostics Market End User, Value (US$ Bn), 2018 - 2030
8.5.1.5. South Africa Biosensors for Point-of-Care Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
8.5.1.6. South Africa Biosensors for Point-of-Care Diagnostics Market Transducer, Value (US$ Bn), 2018 - 2030
8.5.1.7. South Africa Biosensors for Point-of-Care Diagnostics Market Application, Value (US$ Bn), 2018 - 2030
8.5.1.8. South Africa Biosensors for Point-of-Care Diagnostics Market End User, Value (US$ Bn), 2018 - 2030
8.5.1.9. Rest of Middle East & Africa Biosensors for Point-of-Care Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
8.5.1.10. Rest of Middle East & Africa Biosensors for Point-of-Care Diagnostics Market Transducer, Value (US$ Bn), 2018 - 2030
8.5.1.11. Rest of Middle East & Africa Biosensors for Point-of-Care Diagnostics Market Application, Value (US$ Bn), 2018 - 2030
8.5.1.12. Rest of Middle East & Africa Biosensors for Point-of-Care Diagnostics Market End User, Value (US$ Bn), 2018 - 2030
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Product vs Application Heatmap
9.2. Company Market Share Analysis, 2022
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Danaher Corporation
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Bio-Rad Laboratories Inc.
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Zimmer & Peacock AS
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Medtronic plc
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Koninklijke Philips N.V.
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Abbott Laboratories
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Universal Biosensors, Inc.
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Biosensors International Group, Ltd.
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Business Strategies and Development
9.4.9. Johnson & Johnson
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Masimo Corporation
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
9.4.11. QTL Biodetection LLC
9.4.11.1. Company Overview
9.4.11.2. Product Portfolio
9.4.11.3. Financial Overview
9.4.11.4. Business Strategies and Development
9.4.12. Nova Biomedical
9.4.12.1. Company Overview
9.4.12.2. Product Portfolio
9.4.12.3. Financial Overview
9.4.12.4. Business Strategies and Development
9.4.13. Innovative Sensor Technology IST AG
9.4.13.1. Company Overview
9.4.13.2. Product Portfolio
9.4.13.3. Financial Overview
9.4.13.4. Business Strategies and Development
9.4.14. Siemens Healthineers AG
9.4.14.1. Company Overview
9.4.14.2. Product Portfolio
9.4.14.3. Financial Overview
9.4.14.4. Business Strategies and Development
9.4.15. F. Hoffmann-La Roche Ltd.
9.4.15.1. Company Overview
9.4.15.2. Product Portfolio
9.4.15.3. Financial Overview
9.4.15.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Methodology

Loading
LOADING...